Telehealth & Digital Health

After an 8-year hiatus, Elizabeth Arden launches Eternal Aura. A look at the strategy combining a new star, wellness science, and heritage to reclaim its spot.

With promising data in cancer and eczema, all eyes are on Corvus Pharmaceuticals as it presents its lead drug at a major healthcare conference this week.

As Legacy Community Health embarks on a historic expansion, new COO Aaron Stewart is tasked with steering Texas's largest FQHC to serve more communities.

Beyond prize money, CharmHealth's annual challenge builds an ecosystem for healthtech startups, offering a direct path from AI-driven ideas to market impact.

After gaining FDA alignment, INmune Bio is advancing its inflammation-targeting drug, XPro1595, offering a novel and potentially safer approach for patients.

The AI health platform's latest acquisition integrates a specialized pregnancy app, promising a new era of proactive, data-driven maternal care for families.

The Biocodex Microbiota Foundation opens its 10th annual grant, committing a total of half a million dollars to shape the future of U.S. gut health science.

A landmark FDA approval for Bracco's VUEWAY allows high-quality MRI scans in neonates with half the standard gadolinium dose, easing safety concerns.

A Swiss firm begins human trials for a non-glucose dialysis solution, aiming to end a 30-year reliance on problematic treatments for kidney patients.

Teva and Medincell’s once-monthly olanzapine injection shows promise in trials, potentially freeing patients from burdensome post-injection observation.

New research reveals how clinical trial design inflates the placebo effect, offering a key to solving the 90% failure rate for anxiety and depression drugs.

MAIA Pharmaceuticals will bring Teribone™, a proven therapy used in Japan, to the US, aiming to solve the critical patient adherence crisis in osteoporosis care.

The Hume Band challenges rivals with a no-subscription model and longevity tracking, but user complaints and questions about its tech cloud its bold promises.

A new digital health partnership embeds AI coaching into a wellness app, promising 24/7 support for mental health and chronic conditions at scale.

A new partnership model merges virtual nephrology, clinical trials, and real-world data, aiming to empower independent doctors and improve patient access.

The spatial biology leader will unveil its roadmap at AGBT 2026, targeting the next frontiers of drug discovery with 3D imaging and human-relevant models.

The mobile health firm now reaches 25 states with its tech-driven model, aiming to close care gaps and answer federal critics of in-home assessments.

New five-year data for SYFOVRE shows a significant delay in geographic atrophy progression, offering long-term hope but also sparking clinical debate.

With a pivotal data release on the horizon, Passage Bio heads to two major conferences. Can its dementia gene therapy program win over Wall Street?

Serina Therapeutics enrolls the first patient in a trial for SER-252, a novel Parkinson's therapy designed to improve symptoms without current side effects.